In addition, the literature supports an exponential relationship between CSC abundance and CD44 levels within cervical tumours as well as the ability of high‐risk HPV oncogenes E6 and E7 to further promote an increase in CSCs [27], and thus a subsequent increase in CD44 expression. The gene discussed is CD44; the disease is uterine cervix neoplasm.